OMERS Administration Corp’s Neurocrine Biosciences NBIX Stock Holding History

OMERS Administration Corp’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$608K	Buy	4,615 +1,068	+30%	+$142K	﹤0.01%	742
2025 Q4	$503K	Hold	3,547	–	–	﹤0.01%	664
2025 Q3	$498K	Hold	3,547	–	–	﹤0.01%	737
2025 Q2	$446K	Hold	3,547	–	–	﹤0.01%	669
2025 Q1	$392K	Sell	3,547 -587	-14%	-$74.4K	﹤0.01%	800
2024 Q4	$564K	Buy	4,134 +714	+21%	+$88.3K	﹤0.01%	669
2024 Q3	$394K	Sell	3,420 -2,700	-44%	-$370K	﹤0.01%	706
2024 Q2	$843K	Buy	+6,120	New	+$839K	0.01%	571
2016 Q4	–	Sell	-118,300	Closed	-$5.99M	–	471
2016 Q3	$5.99M	Buy	118,300 +79,300	+203%	+$3.95M	0.11%	131
2016 Q2	$1.77M	Buy	+39,000	New	+$1.8M	0.04%	255

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMERS Administration Corp's NBIX Position: Q1 2026 in Review

OMERS Administration Corp increased its Neurocrine Biosciences (NBIX) stake by 30% in Q1 2026, buying an estimated $142K and bringing the position to 4,615 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #742.

OMERS Administration Corp first reported a position in NBIX in Q2 2016 and has held it in 10 quarters since. The position peaked at $5.99M in Q3 2016. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

OMERS Administration Corp held 4,615 shares of Neurocrine Biosciences worth $608K as of Q1 2026.
OMERS Administration Corp bought 1,068 Neurocrine Biosciences shares in Q1 2026, an estimated $142K.
Neurocrine Biosciences made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #742 holding.
OMERS Administration Corp first reported a position in Neurocrine Biosciences in Q2 2016 and has held it in 10 quarters since.
OMERS Administration Corp's Neurocrine Biosciences position peaked at $5.99M in Q3 2016.
694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.